Venous thromboembolism typically manifests itself between 5 to 10 days after surgery. The presence of breathlessness increases the likelihood of a diagnosis of venous thromboembolism as opposed to cellulitis or urinary tract infection. Meanwhile, pulmonary atelectasis is more prone to occur in the earlier stages following surgery.

Post-operative pyrexia, or fever, can occur after surgery and can be caused by various factors. Early causes of post-op pyrexia, which typically occur within the first five days after surgery, include blood transfusion, cellulitis, urinary tract infection, and a physiological systemic inflammatory reaction that usually occurs within a day following the operation. Pulmonary atelectasis is also often listed as an early cause, but the evidence to support this link is limited. Late causes of post-op pyrexia, which occur more than five days after surgery, include venous thromboembolism, pneumonia, wound infection, and anastomotic leak.

To remember the possible causes of post-op pyrexia, it is helpful to use the memory aid of the 4 W’s: wind, water, wound, and what did we do? (iatrogenic). This means that the causes can be related to respiratory issues (wind), urinary tract or other fluid-related problems (water), wound infections or complications (wound), or something that was done during the surgery or post-operative care (iatrogenic). It is important to identify the cause of post-op pyrexia and treat it promptly to prevent further complications. This information is based on a peer-reviewed publication available on the National Center for Biotechnology Information website.

Proteus mirabilis is responsible for the majority of Proteus infections due to its ability to produce urease. This enzyme promotes urinary alkalinisation, which is a necessary condition for the development of staghorn calculi.

Renal Stones: Types and Factors

Renal stones, also known as kidney stones, are solid masses formed in the kidneys from substances found in urine. There are different types of renal stones, each with its own unique features and risk factors. Calcium oxalate stones are the most common type, accounting for 85% of all calculi. Hypercalciuria, hyperoxaluria, and hypocitraturia are major risk factors for calcium oxalate stones. Cystine stones, which are caused by an inherited recessive disorder of transmembrane cystine transport, are relatively rare, accounting for only 1% of all calculi. Uric acid stones, which are formed from purine metabolism, are more common in children with inborn errors of metabolism and are radiolucent. Calcium phosphate stones, which are radio-opaque, may occur in renal tubular acidosis, and high urinary pH increases the supersaturation of urine with calcium and phosphate. Struvite stones, which are slightly radio-opaque, are formed from magnesium, ammonium, and phosphate and are associated with chronic infections.

The pH of urine plays a crucial role in stone formation. Urine pH varies from 5-7, with postprandial pH falling as purine metabolism produces uric acid. The urine then becomes more alkaline, known as the alkaline tide. The pH of urine can help determine which type of stone was present when the stone is not available for analysis. Calcium phosphate stones form in normal to alkaline urine with a pH greater than 5.5, while uric acid stones form in acidic urine with a pH of 5.5 or less. Struvite stones form in alkaline urine with a pH greater than 7.2, and cystine stones form in normal urine with a pH of 6.5.

In summary, renal stones are a common condition with various types and risk factors. Understanding the type of stone and the pH of urine can help in the diagnosis and management of renal stones.

Antimuscarinic medications are effective in managing symptoms of overactive bladder. This condition is characterized by storage symptoms such as urinary urgency, frequency, and nocturia, often caused by detrusor overactivity. Oxybutynin is an example of an antimuscarinic drug that can increase bladder capacity by relaxing the detrusor’s smooth muscle, thereby reducing overactive bladder symptoms. Other antimuscarinic drugs include tolterodine and darifenacin. While botulinum toxin injection is an invasive treatment option for overactive bladder, it is not typically the first choice. Finasteride, a 5 alpha-reductase inhibitor, is not indicated for overactive bladder treatment as it is used to decrease prostate size in BPH patients. Mirabegron, a beta-3 adrenergic receptor agonist, can also relax the detrusor’s smooth muscle, but it is only recommended when antimuscarinic drugs are not effective or contraindicated due to side effects.

Lower urinary tract symptoms (LUTS) are a common issue in men over the age of 50, with benign prostatic hyperplasia being the most common cause. However, other causes such as prostate cancer should also be considered. These symptoms can be classified into three groups: voiding, storage, and post-micturition. To properly manage LUTS, it is important to conduct a urinalysis to check for infection and haematuria, perform a digital rectal examination to assess the size and consistency of the prostate, and possibly conduct a PSA test after proper counselling. Patients should also complete a urinary frequency-volume chart and an International Prostate Symptom Score to guide management.

For predominantly voiding symptoms, conservative measures such as pelvic floor muscle training, bladder training, and prudent fluid intake can be helpful. If symptoms are moderate or severe, an alpha-blocker may be offered. If the prostate is enlarged and the patient is at high risk of progression, a 5-alpha reductase inhibitor should be offered. If there are mixed symptoms of voiding and storage not responding to an alpha-blocker, an antimuscarinic drug may be added. For predominantly overactive bladder symptoms, moderating fluid intake and bladder retraining should be offered, and antimuscarinic drugs may be prescribed if symptoms persist. Mirabegron may be considered if first-line drugs fail. For nocturia, moderating fluid intake at night, furosemide 40 mg in the late afternoon, and desmopressin may be helpful.

Starting management for metastatic prostate cancer with GnRH agonists may lead to a phenomenon called tumour flare, which can cause bone pain, bladder obstruction, and other symptoms. This was observed in a 78-year-old man who presented with urinary retention and bone pain after recently starting treatment. GnRH agonists work by overstimulating the hormone cascade to suppress testosterone production, which initially causes an increase in testosterone levels before subsequent suppression. Bicalutamide is not the best answer as it does not cause the testosterone surge seen with GnRH agonist use. Bilateral orchidectomy is not typically associated with tumour flare as it aims to rapidly decrease testosterone levels. GnRH antagonists, such as degarelix, may be a better option as they avoid the risk of tumour flare by avoiding the testosterone surge.

Management of Prostate Cancer

Localised prostate cancer (T1/T2) can be managed through various treatment options depending on the patient’s life expectancy and preference. Conservative approaches such as active monitoring and watchful waiting can be considered, as well as radical prostatectomy and radiotherapy (external beam and brachytherapy). On the other hand, localised advanced prostate cancer (T3/T4) may require hormonal therapy, radical prostatectomy, or radiotherapy. However, patients who undergo radiotherapy may develop proctitis and are at a higher risk of bladder, colon, and rectal cancer.

For metastatic prostate cancer, the primary goal is to reduce androgen levels. A combination of approaches is often used, including anti-androgen therapy, synthetic GnRH agonist or antagonists, bicalutamide, cyproterone acetate, abiraterone, and bilateral orchidectomy. GnRH agonists such as Goserelin (Zoladex) may result in lower LH levels longer term by causing overstimulation, which disrupts endogenous hormonal feedback systems. This may cause a rise in testosterone initially for around 2-3 weeks before falling to castration levels. To prevent a rise in testosterone, anti-androgen therapy is often used initially. However, this may result in a tumour flare, which stimulates prostate cancer growth and may cause bone pain, bladder obstruction, and other symptoms. GnRH antagonists such as degarelix are being evaluated to suppress testosterone while avoiding the flare phenomenon. Chemotherapy with docetaxel may also be an option for the treatment of hormone-relapsed metastatic prostate cancer in patients who have no or mild symptoms after androgen deprivation therapy has failed, and before chemotherapy is indicated.

Peripheral arterial disease can be improved with exercise training, which has been shown to be beneficial. In addition to lifestyle modifications such as weight loss, smoking cessation, and diet, patients should be referred to smoking cessation services and have their comorbidities managed. Aspirin is already being taken by this patient due to a previous myocardial infarction. Naftidrofuryl oxalate is a vasodilator drug used in the treatment of peripheral arterial disease, but exercise training should be recommended first. Angioplasty is a treatment for severe peripheral arterial disease or critical limb ischaemia, which is not applicable to this patient with an ABPI of 0.67 suggesting intermittent claudication. Amputation is a last resort for irreversible limb ischaemia. Bypass surgery is another potential treatment for critical limb ischaemia, but surgical options would only be considered if conservative management, such as exercise training, failed.

Peripheral arterial disease (PAD) is a condition that is strongly associated with smoking. Therefore, patients who still smoke should be provided with assistance to quit smoking. It is also important to treat any comorbidities that the patient may have, such as hypertension, diabetes mellitus, and obesity. All patients with established cardiovascular disease, including PAD, should be taking a statin, with Atorvastatin 80 mg being the recommended dosage. In 2010, NICE published guidance recommending the use of clopidogrel as the first-line treatment for PAD patients instead of aspirin. Exercise training has also been shown to have significant benefits, and NICE recommends a supervised exercise program for all PAD patients before other interventions.

For severe PAD or critical limb ischaemia, there are several treatment options available. Endovascular revascularization and percutaneous transluminal angioplasty with or without stent placement are typically used for short segment stenosis, aortic iliac disease, and high-risk patients. On the other hand, surgical revascularization, surgical bypass with an autologous vein or prosthetic material, and endarterectomy are typically used for long segment lesions, multifocal lesions, lesions of the common femoral artery, and purely infrapopliteal disease. Amputation should only be considered for patients with critical limb ischaemia who are not suitable for other interventions such as angioplasty or bypass surgery.

There are also drugs licensed for use in PAD, including naftidrofuryl oxalate, a vasodilator sometimes used for patients with a poor quality of life. Cilostazol, a phosphodiesterase III inhibitor with both antiplatelet and vasodilator effects, is not recommended by NICE.

Medication Management for Diabetic Patients on the Day of Surgery

When managing medication for diabetic patients on the day of surgery, it is important to consider the potential risks and benefits of each medication. Here are some guidelines for different scenarios:

– Omit Metformin on the day of surgery. Omit the morning Gliclazide, and take the dinner time Gliclazide if she is able to eat.
– Omit Metformin the day before and on the day. Take Gliclazide as normal.
– Take Metformin as normal. Omit Gliclazide.
– Omit Metformin the day before and on the day. Omit Gliclazide on the day of surgery.
– Omit Metformin on the day of surgery. Halve the Gliclazide doses at lunchtime and dinner.

It is important to note that these guidelines may vary depending on the individual patient’s medical history and current condition. It is recommended to consult with a healthcare professional for personalized medication management.

If a woman under 30 years old presents with an unexplained breast lump with or without pain, she may not meet the 2-week-wait referral criteria but can still be referred for further evaluation. The most likely diagnosis is a fibroadenoma, which is a common benign breast lump that often occurs in younger women. These lumps are typically firm, smooth, and highly mobile. It is important to refer the patient to a breast clinic for evaluation, but routine referral is sufficient given the low likelihood of cancer. Mammograms or ultrasounds are not necessary at this stage. Reviewing the patient in one month is also unnecessary as the lump has already persisted for two months. Urgent referral is not needed due to the patient’s age and low risk of breast cancer. NICE CKS recommends a 2-week-wait referral for those over 30 years old with an unexplained breast lump, or over 50 years old with unilateral nipple changes. Referral should also be considered for those with skin changes suggestive of breast cancer or those over 30 years old with an unexplained lump in the axilla.

In 2015, NICE released guidelines for referring individuals suspected of having breast cancer. If a person is 30 years or older and has an unexplained breast lump with or without pain, or if they are 50 years or older and have discharge, retraction, or other concerning changes in one nipple only, they should be referred using a suspected cancer pathway referral for an appointment within two weeks. If a person has skin changes that suggest breast cancer or is 30 years or older with an unexplained lump in the axilla, a suspected cancer pathway referral should also be considered. For individuals under 30 years old with an unexplained breast lump with or without pain, non-urgent referral should be considered.

Plasma components pose the highest risk for transfusion associated lung injury.

When plasma components are infused, there is a possibility of transfusion lung injury. This can cause damage to the microvasculature in the lungs, resulting in diffuse infiltrates visible on imaging. Unfortunately, mortality rates are often high in such cases. It is worth noting that a normal central venous pressure (which should be between 0-6 mmHg) is not necessarily indicative of fluid overload.

Understanding Massive Haemorrhage and its Complications

Massive haemorrhage is defined as the loss of one blood volume within 24 hours, the loss of 50% of the circulating blood volume within three hours, or a blood loss of 150ml/minute. In adults, the blood volume is approximately 7% of the total body weight, while in children, it is between 8 and 9% of their body weight.

Massive haemorrhage can lead to several complications, including hypothermia, hypocalcaemia, hyperkalaemia, delayed type transfusion reactions, transfusion-related lung injury, and coagulopathy. Hypothermia occurs because the blood is refrigerated, which impairs homeostasis and shifts the Bohr curve to the left. Hypocalcaemia may occur because both fresh frozen plasma (FFP) and platelets contain citrate anticoagulant, which may chelate calcium. Hyperkalaemia may also occur because the plasma of red cells stored for 4-5 weeks contains 5-10 mmol K+.

Delayed type transfusion reactions may occur due to minor incompatibility issues, especially if urgent or non-cross-matched blood is used. Transfusion-related lung injury is the leading cause of transfusion-related deaths and poses the greatest risk with plasma components. It occurs as a result of leucocyte antibodies in transfused plasma, leading to aggregation and degranulation of leucocytes in lung tissue. Finally, coagulopathy is anticipated once the circulating blood volume is transfused. One blood volume usually drops the platelet count to 100 or less, and it will both dilute and not replace clotting factors. The fibrinogen concentration halves per 0.75 blood volume transfused.

In summary, massive haemorrhage can lead to several complications that can be life-threatening. It is essential to understand these complications to manage them effectively and prevent adverse outcomes.

Bilious vomiting in neonates accompanied by a double bubble sign on abdominal X-ray.

Causes and Treatments for Bilious Vomiting in Neonates

Bilious vomiting in neonates can be caused by various disorders, including duodenal atresia, malrotation with volvulus, jejunal/ileal atresia, meconium ileus, and necrotising enterocolitis. Duodenal atresia occurs in 1 in 5000 births and is more common in babies with Down syndrome. It typically presents a few hours after birth and can be diagnosed through an abdominal X-ray that shows a double bubble sign. Treatment involves duodenoduodenostomy. Malrotation with volvulus is usually caused by incomplete rotation during embryogenesis and presents between 3-7 days after birth. An upper GI contrast study or ultrasound can confirm the diagnosis, and treatment involves Ladd’s procedure. Jejunal/ileal atresia is caused by vascular insufficiency in utero and occurs in 1 in 3000 births. It presents within 24 hours of birth and can be diagnosed through an abdominal X-ray that shows air-fluid levels. Treatment involves laparotomy with primary resection and anastomosis. Meconium ileus occurs in 15-20% of babies with cystic fibrosis and presents in the first 24-48 hours of life with abdominal distension and bilious vomiting. Diagnosis involves an abdominal X-ray that shows air-fluid levels, and a sweat test can confirm cystic fibrosis. Treatment involves surgical decompression, and segmental resection may be necessary for serosal damage. Necrotising enterocolitis occurs in up to 2.4 per 1000 births, with increased risks in prematurity and inter-current illness. It typically presents in the second week of life and can be diagnosed through an abdominal X-ray that shows dilated bowel loops, pneumatosis, and portal venous air. Treatment involves conservative and supportive measures for non-perforated cases, while laparotomy and resection are necessary for perforated cases or ongoing clinical deterioration.

It is improbable for pseudocysts to be detected within 4 weeks of an episode of acute pancreatitis. Nevertheless, they are more prevalent during this period and are linked to an elevated amylase level.

Acute pancreatitis can lead to various complications, both locally and systemically. Local complications include peripancreatic fluid collections, which occur in about 25% of cases and may develop into pseudocysts or abscesses. Pseudocysts are walled by fibrous or granulation tissue and typically occur 4 weeks or more after an attack of acute pancreatitis. Pancreatic necrosis, which involves both the pancreatic parenchyma and surrounding fat, can also occur and is directly linked to the extent of necrosis. Pancreatic abscesses may result from infected pseudocysts and can be treated with drainage methods. Haemorrhage may also occur, particularly in cases of infected necrosis.

Systemic complications of acute pancreatitis include acute respiratory distress syndrome, which has a high mortality rate of around 20%. Local complications such as peripancreatic fluid collections and pancreatic necrosis can also lead to systemic complications if left untreated. It is important to manage these complications appropriately, with conservative management being preferred for sterile necrosis and early necrosectomy being avoided unless necessary. Treatment options for local complications include endoscopic or surgical cystogastrostomy, aspiration, and drainage methods. Overall, prompt recognition and management of complications is crucial in improving outcomes for patients with acute pancreatitis.

Preoperative Management for Gastrointestinal Surgery

Surgical site infections are a common complication of gastrointestinal surgery, with up to 60% of emergency procedures resulting in infections. To prevent this, a single dose of broad-spectrum antibiotics, such as Tazocin®, should be given intravenously 30 minutes before the procedure. Patients should also be hydrated with iv fluids and be nil by mouth for at least six hours before surgery. In cases of potential post-operative intestinal obstruction or ileus, a nasogastric tube may be necessary. However, narrow-spectrum antibiotics like iv flucloxacillin are not appropriate for prophylaxis in this case. Finally, VTE prophylaxis with LMWH should be given preoperatively but stopped 12 hours before the procedure.

If a patient is diagnosed with prostatitis, a urine sample should be taken for culture. If the patient is stable enough to be treated outside of a hospital setting, they should be prescribed a 14-day course of a quinolone such as ciprofloxacin or ofloxacin. However, if the patient is experiencing severe symptoms, is septic, unable to take oral antibiotics, or is in urinary retention, they should be referred to secondary care urgently.

Acute bacterial prostatitis is a condition that occurs when gram-negative bacteria enter the prostate gland through the urethra. The most common pathogen responsible for this condition is Escherichia coli. Risk factors for acute bacterial prostatitis include recent urinary tract infection, urogenital instrumentation, intermittent bladder catheterisation, and recent prostate biopsy. Symptoms of this condition include pain in various areas such as the perineum, penis, rectum, or back, obstructive voiding symptoms, fever, and rigors. A tender and boggy prostate gland can be detected during a digital rectal examination.

The recommended treatment for acute bacterial prostatitis is a 14-day course of a quinolone. It is also advisable to consider screening for sexually transmitted infections.

Fasting Guidelines Prior to Surgery

Fasting prior to surgery is important to reduce the risk of regurgitation and aspiration while under anesthesia, which can lead to aspiration pneumonia. The current guidance advises patients to refrain from consuming food for at least 6 hours before surgery. However, clear fluids such as water, fruit squash, tea, or coffee with small amounts of skimmed or semi-skimmed milk can be encouraged up to 2 hours before surgery to maintain hydration and aid in post-operative recovery.

The previous practice of nil by mouth from midnight is now considered unnecessary and outdated. It is now known that maintaining hydration and nutrition peri-operatively can lead to faster post-operative recovery. Patients with diabetes may require a sliding-scale insulin infusion to manage their blood sugar levels before and after surgery.

In summary, the recommended fasting guidelines prior to surgery are no food for 6 hours before surgery and clear fluids up to 2 hours before surgery. These guidelines help to minimize the risk of aspiration while under anesthesia and promote a smoother recovery process.

Preventing Surgical Site Infections

Surgical site infections (SSI) are a common complication following surgery, with up to 20% of all healthcare-associated infections being SSIs. These infections occur when there is a breach in tissue surfaces, allowing normal commensals and other pathogens to initiate infection. In many cases, the organisms causing the infection are derived from the patient’s own body. Measures that may increase the risk of SSI include shaving the wound using a razor, using a non-iodine impregnated incise drape, tissue hypoxia, and delayed administration of prophylactic antibiotics in tourniquet surgery.

To prevent SSIs, there are several steps that can be taken before, during, and after surgery. Before surgery, it is recommended to avoid routine removal of body hair and to use electrical clippers with a single-use head if hair needs to be removed. Antibiotic prophylaxis should be considered for certain types of surgery, such as placement of a prosthesis or valve, clean-contaminated surgery, and contaminated surgery. Local formulary should be used, and a single-dose IV antibiotic should be given on anesthesia. If a tourniquet is to be used, prophylactic antibiotics should be given earlier.

During surgery, the skin should be prepared with alcoholic chlorhexidine, which has been shown to have the lowest incidence of SSI. The surgical site should be covered with a dressing, and wound edge protectors do not appear to confer any benefit. Postoperatively, tissue viability advice should be given for the management of surgical wounds healing by secondary intention. The use of diathermy for skin incisions is not advocated in the NICE guidelines, but several randomized controlled trials have demonstrated no increase in the risk of SSI when diathermy is used.

Bowel prep is necessary for a colonoscopy.

Preparation for surgery varies depending on whether the patient is undergoing an elective or emergency procedure. For elective cases, it is important to address any medical issues beforehand through a pre-admission clinic. Blood tests, urine analysis, and other diagnostic tests may be necessary depending on the proposed procedure and patient fitness. Risk factors for deep vein thrombosis should also be assessed, and a plan for thromboprophylaxis formulated. Patients are advised to fast from non-clear liquids and food for at least 6 hours before surgery, and those with diabetes require special management to avoid potential complications. Emergency cases require stabilization and resuscitation as needed, and antibiotics may be necessary. Special preparation may also be required for certain procedures, such as vocal cord checks for thyroid surgery or bowel preparation for colorectal cases.

The patient’s risk factors and clinical features suggest a diagnosis of acute coronary syndrome (ACS), which requires urgent investigation. An ECG should be performed to aid in diagnosis and guide immediate management. While an abdominal ultrasound may be useful in investigating his symptoms, other more urgent investigations should be prioritized. An abdominal x-ray is unlikely to be helpful in this case, and a chest x-ray may be requested due to the patient’s history of breathlessness. Blood tests may be useful in investigating the cause of his abdominal pain, but should not be the first investigation.

Exam Features of Abdominal Pain Conditions

Abdominal pain can be caused by various conditions, and it is important to be familiar with their characteristic exam features. Peptic ulcer disease, for instance, may present with epigastric pain that is relieved by eating in duodenal ulcers and worsened by eating in gastric ulcers. Appendicitis, on the other hand, may initially cause pain in the central abdomen before localizing to the right iliac fossa, accompanied by anorexia, tenderness in the right iliac fossa, and a positive Rovsing’s sign. Acute pancreatitis, which is often due to alcohol or gallstones, may manifest as severe epigastric pain and vomiting, with tenderness, ileus, and low-grade fever on examination.

Other conditions that may cause abdominal pain include biliary colic, diverticulitis, and intestinal obstruction. Biliary colic may cause pain in the right upper quadrant that radiates to the back and interscapular region, while diverticulitis may present with colicky pain in the left lower quadrant, fever, and raised inflammatory markers. Intestinal obstruction, which may be caused by malignancy or previous operations, may lead to vomiting, absence of bowel movements, and tinkling bowel sounds.

It is also important to remember that some conditions may have unusual or medical causes of abdominal pain, such as acute coronary syndrome, diabetic ketoacidosis, pneumonia, acute intermittent porphyria, and lead poisoning. Therefore, being familiar with the characteristic exam features of various conditions can aid in the diagnosis and management of abdominal pain.

For patients with troublesome symptoms of benign prostatic hyperplasia, alpha-1 antagonists are the first-line medication to consider. This is particularly true for patients with predominantly voiding symptoms, such as the patient in this case who has an IPPS of 15. Alpha-1 agonists like tamsulosin and alfuzosin are recommended for patients with moderate-to-severe voiding symptoms (IPSS ≥ 8) and are likely to provide relief for this patient’s symptoms.

On the other hand, 5-alpha reductase inhibitors are only indicated for patients with significantly enlarged prostates, which is not the case for this patient. Therefore, they are not appropriate for him at this time. Similarly, anti-muscarinic medication is only recommended for patients with a combination of storage and voiding symptoms that persist after treatment with an alpha-blocker alone. Since this patient only reports voiding symptoms and is not currently on any treatment, this class of medication is not indicated for him.

Finally, GnRH analogues are commonly used in prostate cancer treatment, but they have been found to have a poor side effect profile when used for benign prostatic hypertrophy. As a result, they are not appropriate for this patient.

Benign prostatic hyperplasia (BPH) is a common condition that affects older men, with around 50% of 50-year-old men showing evidence of BPH and 30% experiencing symptoms. The risk of BPH increases with age, with around 80% of 80-year-old men having evidence of the condition. BPH typically presents with lower urinary tract symptoms (LUTS), which can be categorised into voiding symptoms (obstructive) and storage symptoms (irritative). Complications of BPH can include urinary tract infections, retention, and obstructive uropathy.

Assessment of BPH may involve dipstick urine tests, U&Es, and PSA tests. A urinary frequency-volume chart and the International Prostate Symptom Score (IPSS) can also be used to assess the severity of LUTS and their impact on quality of life. Management options for BPH include watchful waiting, alpha-1 antagonists, 5 alpha-reductase inhibitors, combination therapy, and surgery. Alpha-1 antagonists are considered first-line treatment for moderate-to-severe voiding symptoms, while 5 alpha-reductase inhibitors may be indicated for patients with significantly enlarged prostates and a high risk of progression. Combination therapy and antimuscarinic drugs may also be used in certain cases. Surgery, such as transurethral resection of the prostate (TURP), may be necessary in severe cases.

In cases of perforation of the rectosigmoid bowel leading to peritonitis, an emergency Hartmann’s procedure may be necessary. This involves removing the affected portion of the colon, creating an end colostomy, and sewing the rectal stump. The perforation may be caused by conditions such as colon cancer, diverticulitis, or trauma. The colostomy is typically placed on the left side of the abdomen and sewn flush with the skin.

Colorectal cancer is typically diagnosed through CT scans and colonoscopies or CT colonography. Patients with tumors below the peritoneal reflection should also undergo MRI to evaluate their mesorectum. Once staging is complete, a treatment plan is formulated by a dedicated colorectal MDT meeting.

For colon cancer, surgery is the primary treatment option, with resectional surgery being the only cure. The procedure is tailored to the patient and tumor location, with lymphatic chains being resected based on arterial supply. Anastomosis is the preferred method of restoring continuity, but in some cases, an end stoma may be necessary. Chemotherapy is often offered to patients with risk factors for disease recurrence.

Rectal cancer management differs from colon cancer due to the rectum’s anatomical location. Tumors can be surgically resected with either an anterior resection or an abdominoperineal excision of rectum (APER). A meticulous dissection of the mesorectal fat and lymph nodes is integral to the procedure. Neoadjuvant radiotherapy is often offered to patients prior to resectional surgery, and those with obstructing rectal cancer should have a defunctioning loop colostomy.

Segmental resections based on blood supply and lymphatic drainage are the primary operations for cancer. The type of resection and anastomosis depend on the site of cancer. In emergency situations where the bowel has perforated, an end colostomy is often safer. Left-sided resections are more risky, but ileocolic anastomoses are relatively safe even in the emergency setting and do not need to be defunctioned.

Acute epididymo-orchitis cases are commonly caused by enteric organisms (such as Escherichia coli or Enterococcus faecalis) in men aged 35 years and above. This type of infection is often linked to urinary tract infections and may be related to structural issues in the urinary tract.

Epididymo-orchitis is a condition where the epididymis and/or testes become infected, leading to pain and swelling. It is commonly caused by infections spreading from the genital tract or bladder, with Chlamydia trachomatis and Neisseria gonorrhoeae being the usual culprits in sexually active younger adults, while E. coli is more commonly seen in older adults with a low-risk sexual history. Symptoms include unilateral testicular pain and swelling, with urethral discharge sometimes present. Testicular torsion, which can cause ischaemia of the testicle, is an important differential diagnosis and needs to be excluded urgently, especially in younger patients with severe pain and an acute onset.

Investigations are guided by the patient’s age, with sexually transmitted infections being assessed in younger adults and a mid-stream urine (MSU) being sent for microscopy and culture in older adults with a low-risk sexual history. Management guidelines from the British Association for Sexual Health and HIV (BASHH) recommend ceftriaxone 500 mg intramuscularly as a single dose, plus doxycycline 100 mg orally twice daily for 10-14 days if the organism causing the infection is unknown. Further investigations are recommended after treatment to rule out any underlying structural abnormalities.

Complications of Colles’ Fracture

Colles’ fracture is a type of fracture that occurs at the lower end of the radius, often accompanied by a fracture of the ulnar styloid process. It is commonly seen in elderly women who fall on their outstretched hand. While this type of fracture can be treated, there are three main complications that can arise.

The first complication is malunion, which occurs when the displacement is not fully corrected during manipulation. This can lead to deformity and limited wrist movements, delayed rupture of the extensor tendon, and carpal tunnel syndrome. The second complication is stiffness of the fingers and wrist, which can occur if the finger joints are not exercised during the immobilization period. Finally, Sudeck’s atrophy is a rare complication that causes severe pain in the hand and wrist, swelling, and circulatory disturbance in the hand with oedema, resulting in painful stiffness of all joints of the hands.

It is important to be aware of these complications when treating Colles’ fracture to ensure proper healing and prevent long-term issues.

The appropriate test to be conducted on all men with erectile dysfunction is the morning testosterone level check. Checking for Chlamydia and gonorrhoeae NAAT is not necessary. Prolactin and FSH/LH should only be checked if the testosterone level is low. Referring for counseling may be considered if psychological factors are suspected, but other tests should be conducted first. Endocrinology referral is not necessary at this stage, but may be considered if the testosterone level is found to be reduced.

Erectile dysfunction (ED) is a condition where a man is unable to achieve or maintain an erection that is sufficient for sexual activity. It is not a disease but a symptom that can be caused by organic, psychogenic, or mixed factors. It is important to differentiate between the causes of ED, with gradual onset of symptoms, lack of tumescence, and normal libido favoring an organic cause, while sudden onset of symptoms, decreased libido, and major life events favoring a psychogenic cause. Risk factors for ED include cardiovascular disease, alcohol use, and certain medications.

To assess for ED, it is recommended to measure lipid and fasting glucose serum levels to calculate cardiovascular risk, as well as free testosterone levels in the morning. If free testosterone is low or borderline, further assessment may be needed. PDE-5 inhibitors, such as sildenafil, are the first-line treatment for ED and should be prescribed to all patients regardless of the cause. Vacuum erection devices can be used as an alternative for those who cannot or will not take PDE-5 inhibitors.

For young men who have always had difficulty achieving an erection, referral to urology is appropriate. Additionally, people with ED who cycle for more than three hours per week should be advised to stop. Overall, ED is a common condition that can be effectively managed with appropriate treatment.

When a patient with acute PR bleeds is haemodynamically stable, the primary treatment approach is supportive management. In this scenario, the patient is likely suffering from haemorrhoids. Supportive management involves providing analgesia for pain relief, regular monitoring of the patient’s condition, and administering fluids and oxygen as necessary.

If the patient shows signs of haemodynamic compromise, intravenous fluids and/or blood transfusions may be necessary. Endoscopy is a useful tool for identifying the underlying cause of the bleed. Colonoscopy is typically used in elective settings, while flexible sigmoidoscopy is effective in identifying haemorrhoids as the source of the bleed.

Understanding Lower Gastrointestinal Bleeding

Lower gastrointestinal bleeding, also known as colonic bleeding, is characterized by the presence of bright red or dark red blood in the rectum. Unlike upper gastrointestinal bleeding, colonic bleeding rarely presents as melaena type stool. This is because blood in the colon has a powerful laxative effect and is rarely retained long enough for transformation to occur. Additionally, the digestive enzymes present in the small bowel are not present in the colon. It is important to note that up to 15% of patients presenting with hematochezia will have an upper gastrointestinal source of haemorrhage.

Right-sided bleeds tend to present with darker coloured blood than left-sided bleeds. Haemorrhoidal bleeding, on the other hand, typically presents as bright red rectal bleeding that occurs post defecation either onto toilet paper or into the toilet pan. However, it is very unusual for haemorrhoids alone to cause any degree of haemodynamic compromise.

There are several causes of lower gastrointestinal bleeding, including colitis, diverticular disease, cancer, and angiodysplasia. The management of lower gastrointestinal bleeding involves prompt correction of any haemodynamic compromise. Unlike upper gastrointestinal bleeding, the first-line management is usually supportive. When haemorrhoidal bleeding is suspected, a proctosigmoidoscopy is reasonable as attempts at full colonoscopy are usually time-consuming and often futile. In the unstable patient, the usual procedure would be an angiogram, while in others who are more stable, a colonoscopy in the elective setting is the standard procedure. Surgery may be necessary in some cases, particularly in patients over 60 years, those with continued bleeding despite endoscopic intervention, and those with recurrent bleeding.

In summary, lower gastrointestinal bleeding is a serious condition that requires prompt attention. It is important to identify the cause of the bleeding and manage it accordingly to prevent further complications.

If a patient experiences abdominal pain, it is likely that they have a symptomatic AAA which poses a high risk of rupture. In such cases, surgical intervention, specifically endovascular repair (EVAR), is necessary rather than relying on medical treatment or observation. To be classified as high rupture risk, the abdominal aortic diameter must exceed 5.5 cm, which is a close call. The presence of trace free fluid is generally considered normal. Conservative measures, such as quitting smoking, should be taken to address cardiovascular risk factors. An AAA is only considered high-risk due to velocity of growth if it increases by more than 1 cm per year, which equates to a velocity of growth of 0.3 cm over 6 months or 0.6cm over 1 year. Ultimately, the decision to proceed with elective surgery is a complex one that should be made in consultation with the patient and surgeon.

Abdominal aortic aneurysm (AAA) is a condition that often develops without any symptoms. However, a ruptured AAA can be fatal, which is why it is important to screen patients for this condition. Screening involves a single abdominal ultrasound for males aged 65. The results of the screening are interpreted based on the width of the aorta. If the width is less than 3 cm, no further action is needed. If it is between 3-4.4 cm, the patient should be rescanned every 12 months. For a width of 4.5-5.4 cm, the patient should be rescanned every 3 months. If the width is 5.5 cm or more, the patient should be referred to vascular surgery within 2 weeks for probable intervention.

For patients with a low risk of rupture, which includes those with a small or medium aneurysm (i.e. aortic diameter less than 5.5 cm) and no symptoms, abdominal US surveillance should be conducted on the time-scales outlined above. Additionally, cardiovascular risk factors should be optimized, such as quitting smoking. For patients with a high risk of rupture, which includes those with a large aneurysm (i.e. aortic diameter of 5.5 cm or more) or rapidly enlarging aneurysm (more than 1 cm/year) or those with symptoms, they should be referred to vascular surgery within 2 weeks for probable intervention. Treatment for these patients may involve elective endovascular repair (EVAR) or open repair if EVAR is not suitable. EVAR involves placing a stent into the abdominal aorta via the femoral artery to prevent blood from collecting in the aneurysm. However, a complication of EVAR is an endo-leak, which occurs when the stent fails to exclude blood from the aneurysm and usually presents without symptoms on routine follow-up.

This is classified as Dukes C due to the presence of lymph node involvement. In the Astler Coller classification system, subsets B and C are further divided into B1, B2, C1, and C2. C2 specifically indicates the involvement of lymph nodes along with the penetration of the muscularis propria.

Dukes’ Classification: Stages of Colorectal Cancer

Dukes’ classification is a system used to describe the extent of spread of colorectal cancer. It is divided into four stages, each with a different level of severity and prognosis. Stage A refers to a tumour that is confined to the mucosa, with a 95% 5-year survival rate. Stage B describes a tumour that has invaded the bowel wall, with an 80% 5-year survival rate. Stage C indicates the presence of lymph node metastases, with a 65% 5-year survival rate. Finally, Stage D refers to distant metastases, with a 5% 5-year survival rate (although this increases to 20% if the metastases are resectable).

Overall, Dukes’ classification is an important tool for doctors to use when determining the best course of treatment for patients with colorectal cancer. By understanding the stage of the cancer, doctors can make more informed decisions about surgery, chemotherapy, and other treatments. Additionally, patients can use this information to better understand their prognosis and make decisions about their own care.

The most likely cause of a fever developing within the first 24 hours after surgery in an otherwise healthy patient is a physiological reaction to the operation. This is due to the inflammatory response to tissue damage caused by the surgery. Other potential causes such as cellulitis, pneumonia, and pulmonary embolism are less likely due to the absence of other symptoms and vital sign changes. Cellulitis may present with red and tender wounds, but without changes in other vital signs, it is not the likely cause. Pneumonia and pulmonary embolism typically occur after 48 hours and 2-10 days respectively, and would be accompanied by changes in heart and respiratory rates, which were not observed in this patient.

Post-operative pyrexia, or fever, can occur after surgery and can be caused by various factors. Early causes of post-op pyrexia, which typically occur within the first five days after surgery, include blood transfusion, cellulitis, urinary tract infection, and a physiological systemic inflammatory reaction that usually occurs within a day following the operation. Pulmonary atelectasis is also often listed as an early cause, but the evidence to support this link is limited. Late causes of post-op pyrexia, which occur more than five days after surgery, include venous thromboembolism, pneumonia, wound infection, and anastomotic leak.

To remember the possible causes of post-op pyrexia, it is helpful to use the memory aid of the 4 W’s: wind, water, wound, and what did we do? (iatrogenic). This means that the causes can be related to respiratory issues (wind), urinary tract or other fluid-related problems (water), wound infections or complications (wound), or something that was done during the surgery or post-operative care (iatrogenic). It is important to identify the cause of post-op pyrexia and treat it promptly to prevent further complications. This information is based on a peer-reviewed publication available on the National Center for Biotechnology Information website.

Bladder cancer of squamous origin is the most probable diagnosis considering the patient’s history of residing in high-risk areas and having schistosomiasis. Nephrolithiasis, on the other hand, would cause renal colic, which patients describe as intense pain waves and discomfort. Clear cell carcinoma, although the most common subtype of renal cell carcinoma, is still less prevalent than bladder cancer and would not result in bladder symptoms.

Risk Factors for Bladder Cancer

Bladder cancer is a type of cancer that affects the bladder, and there are different types of bladder cancer. The most common type is urothelial (transitional cell) carcinoma, and the risk factors for this type of bladder cancer include smoking, exposure to aniline dyes, rubber manufacture, and cyclophosphamide. Smoking is the most important risk factor in western countries, with a hazard ratio of around 4. Exposure to aniline dyes, such as working in the printing and textile industry, can also increase the risk of bladder cancer. Rubber manufacture and cyclophosphamide are also risk factors for urothelial carcinoma.

On the other hand, squamous cell carcinoma of the bladder has different risk factors. Schistosomiasis and smoking are the main risk factors for this type of bladder cancer. Schistosomiasis is a parasitic infection that can cause inflammation and damage to the bladder, which can increase the risk of developing squamous cell carcinoma. Smoking is also a risk factor for squamous cell carcinoma, as it can cause changes in the cells of the bladder lining that can lead to cancer.

In summary, the risk factors for bladder cancer depend on the type of cancer. Urothelial carcinoma is mainly associated with smoking, exposure to aniline dyes, rubber manufacture, and cyclophosphamide, while squamous cell carcinoma is mainly associated with schistosomiasis and smoking. It is important to be aware of these risk factors and take steps to reduce your risk of developing bladder cancer.

Hormonal Therapy for Biochemical Relapse in Prostate Cancer

According to NICE guidance, a biochemical relapse in prostate cancer, indicated by a rising PSA level, should not always lead to an immediate change in treatment. Hormonal therapy is not typically recommended for men with prostate cancer who experience a biochemical relapse unless they have symptomatic local disease progression, proven metastases, or a PSA doubling time of less than three months. In other words, if the cancer has not spread beyond the prostate and is not causing any symptoms, hormonal therapy may not be necessary. However, if the cancer has spread or is progressing rapidly, hormonal therapy may be recommended to slow down the cancer’s growth and improve the patient’s quality of life. It is important for patients to discuss their individual circumstances with their healthcare provider to determine the best course of action.

Hearing Aids vs Cochlear Implants

A hearing aid is a device that consists of a microphone, an amplifier, and an earphone. It amplifies incoming sound and delivers it to the outer ear, relying on the normal anatomical and physiological mechanisms of hearing. Recent technology has enabled some manipulation of the input sound, such as filtering out background noise. Hearing aids are helpful for people with mild to moderate hearing loss and, in some cases, moderate to severe loss.

On the other hand, a cochlear implant is not a powerful hearing aid. It bypasses the mechanisms of the outer and middle ear and artificially recreates sound by providing direct electrical stimulation via electrodes situated in the cochlear. The external component, called a speech processor, detects sound via a microphone, extracts useful sound, and changes it into a radio frequency signal transmitted through the skin. The internal portion detects this signal and decodes it, providing stimulation to the appropriate electrode for a given frequency of sound.

For people with severe to profound hearing loss, cochlear implants provide not only more sound but also clarity of sound. In contrast, hearing aids often only provide amplified noise and little useful sound for these individuals. Many long-term hearing aid users with progressive hearing loss or sudden worsening of hearing go on to receive a cochlear implant and receive great benefit.

In summary, while hearing aids and cochlear implants both aim to improve hearing, they differ in their mechanisms and effectiveness for different levels of hearing loss.

An ultrasound is the initial test for investigating a testicular mass. It is common for there to be a slight size difference between the two testes. The first step is to perform an ultrasound to identify the mass and confirm its presence. If the mass appears to be cancerous, tumor markers should be measured. In cases where the ultrasound results are unclear, an MRI may be necessary.

Understanding Testicular Cancer

Testicular cancer is a type of cancer that commonly affects men between the ages of 20 and 30. Germ-cell tumors are the most common type of testicular cancer, accounting for around 95% of cases. These tumors can be divided into seminomas and non-seminomas, which include embryonal, yolk sac, teratoma, and choriocarcinoma. Other types of testicular cancer include Leydig cell tumors and sarcomas. Risk factors for testicular cancer include infertility, cryptorchidism, family history, Klinefelter’s syndrome, and mumps orchitis.

The most common symptom of testicular cancer is a painless lump, although some men may experience pain. Other symptoms may include hydrocele and gynaecomastia, which occurs due to an increased oestrogen:androgen ratio. Tumor markers such as hCG, AFP, and beta-hCG may be elevated in germ cell tumors. Ultrasound is the first-line diagnostic tool for testicular cancer.

Treatment for testicular cancer depends on the type and stage of the tumor. Orchidectomy, chemotherapy, and radiotherapy may be used. Prognosis for testicular cancer is generally excellent, with a 5-year survival rate of around 95% for seminomas and 85% for teratomas if caught at Stage I. It is important for men to perform regular self-examinations and seek medical attention if they notice any changes or abnormalities in their testicles.

The presence of fever, jaundice and right upper quadrant pain in this patient indicates Charcot’s cholangitis triad, which strongly suggests the possibility of ascending cholangitis, particularly given the history of confirmed gallstones. The recommended course of action is to administer intravenous antibiotics.

Understanding Ascending Cholangitis

Ascending cholangitis is a bacterial infection that affects the biliary tree, with E. coli being the most common culprit. This condition is often associated with gallstones, which can predispose individuals to the infection. Patients with ascending cholangitis may present with Charcot’s triad, which includes fever, right upper quadrant pain, and jaundice. However, this triad is only present in 20-50% of cases. Other common symptoms include hypotension and confusion. In severe cases, Reynolds’ pentad may be observed, which includes the additional symptoms of hypotension and confusion.

To diagnose ascending cholangitis, ultrasound is typically used as a first-line investigation to look for bile duct dilation and stones. Raised inflammatory markers may also be observed. Treatment involves intravenous antibiotics and endoscopic retrograde cholangiopancreatography (ERCP) after 24-48 hours to relieve any obstruction.

Overall, ascending cholangitis is a serious condition that requires prompt diagnosis and treatment. Understanding the symptoms and risk factors associated with this condition can help individuals seek medical attention early and improve their chances of a successful recovery.